{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T05:08:52Z","timestamp":1781154532151,"version":"3.54.1"},"reference-count":293,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.nano.2025.102861","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T05:29:14Z","timestamp":1758950954000},"page":"102861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Targeting the PI3K\/Akt\/mTOR pathway with nanotechnology: A novel therapeutic strategy for gastrointestinal cancers"],"prefix":"10.1016","volume":"69","author":[{"given":"Maryam","family":"Kaviani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Tayebi-Khorrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yegane","family":"Marami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mahdi","family":"Hassanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2025.102861_bb0005","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/clinchem\/hvad202","article-title":"Epidemiology of Cancer","volume":"70","author":"Schwartz","year":"2024","journal-title":"Clin Chem"},{"key":"10.1016\/j.nano.2025.102861_bb0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fmolb.2014.00024","article-title":"Biological response of cancer cells to radiation treatment","volume":"1","author":"Baskar","year":"2014","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.nano.2025.102861_bb0015","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1002\/1878-0261.13291","article-title":"Mitochondrial DNA mutations in ageing and cancer","volume":"16","author":"Smith","year":"2022","journal-title":"Mol Oncol"},{"key":"10.1016\/j.nano.2025.102861_bb0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13167-016-0069-z","article-title":"Environmental and lifestyle risk factors of breast cancer in Malta-a retrospective case-control study","volume":"7","author":"Cauchi","year":"2016","journal-title":"EPMA J"},{"key":"10.1016\/j.nano.2025.102861_bb0025","doi-asserted-by":"crossref","first-page":"4346576","DOI":"10.1155\/2017\/4346576","article-title":"Immunotherapy in gastrointestinal cancers","volume":"2017","author":"Procaccio","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.nano.2025.102861_bb0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.34172\/mejdd.2022.251","article-title":"Gastrointestinal and Pancratohepatobiliary cancers: a comprehensive review on epidemiology and risk factors worldwide","volume":"14","author":"Hormati","year":"2022","journal-title":"Middle East J Dig Dis"},{"key":"10.1016\/j.nano.2025.102861_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20043640","article-title":"The rise of gastrointestinal cancers as a global phenomenon: unhealthy behavior or Progress?","volume":"20","author":"Jardim","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.nano.2025.102861_bb0040","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","article-title":"Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention","volume":"20","author":"Thrift","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.nano.2025.102861_bb0045","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1038\/onc.2014.164","article-title":"mTORC1 drives HIF-1\u03b1 and VEGF-A signalling via multiple mechanisms involving 4E-BP1, S6K1 and STAT3","volume":"34","author":"Dodd","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.nano.2025.102861_bb0050","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/01.cad.0000173476.67239.3b","article-title":"PI3K\/Akt\/mTOR pathway as a target for cancer therapy","volume":"16","author":"Morgensztern","year":"2005","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.nano.2025.102861_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103749","article-title":"Prospects of targeting PI3K\/AKT\/mTOR pathway in pancreatic cancer","volume":"176","author":"Mortazavi","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.nano.2025.102861_bb0060","doi-asserted-by":"crossref","DOI":"10.31083\/j.fbl2802037","article-title":"To investigate the occurrence and development of colorectal cancer based on the PI3K\/AKT\/mTOR signaling pathway","volume":"28","author":"Zhong","year":"2023","journal-title":"Frontiers in Bioscience-Landmark"},{"key":"10.1016\/j.nano.2025.102861_bb0065","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3390\/cancers6031441","article-title":"The role of PI3K\/Akt\/mTOR signaling in gastric carcinoma","volume":"6","author":"Matsuoka","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/j.nano.2025.102861_bb0070","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3390\/biomedicines9111639","article-title":"Targeting the PI3K\/Akt\/mTOR pathway in hepatocellular carcinoma","volume":"9","author":"Sun","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.nano.2025.102861_bb0075","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/jcp.30655","article-title":"The PI3K\/Akt\/mTOR axis in colorectal cancer: oncogenic alterations, non-coding RNAs, therapeutic opportunities, and the emerging role of nanoparticles","volume":"237","author":"Sanaei","year":"2022","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.nano.2025.102861_bb0080","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12935-023-03115-1","article-title":"Metal nanoparticles as a potential technique for the diagnosis and treatment of gastrointestinal cancer: a comprehensive review","volume":"23","author":"Roshani","year":"2023","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.nano.2025.102861_bb0085","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-022-01613-4","article-title":"Application of nanotechnology in the early diagnosis and comprehensive treatment of gastrointestinal cancer","volume":"20","author":"Deng","year":"2022","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.nano.2025.102861_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2014.00064","article-title":"Targeting PI3K\/Akt\/mTOR signaling in cancer","volume":"4","author":"Porta","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.nano.2025.102861_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25031848","article-title":"Targeting PI3K\/AKT\/mTOR and MAPK signaling pathways in gastric cancer","volume":"25","author":"Morgos","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2025.102861_bb0100","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.nano.2025.102861_bb0105","doi-asserted-by":"crossref","first-page":"R1046","DOI":"10.1016\/j.cub.2009.09.058","article-title":"An emerging role of mTOR in lipid biosynthesis","volume":"19","author":"Laplante","year":"2009","journal-title":"Curr Biol"},{"key":"10.1016\/j.nano.2025.102861_bb0110","article-title":"Rapamycin upregulates autophagy by inhibiting the mTOR-ULK1 pathway, resulting in reduced podocyte injury","volume":"8","author":"Wu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2025.102861_bb0115","doi-asserted-by":"crossref","first-page":"23433","DOI":"10.1074\/jbc.C500169200","article-title":"Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency","volume":"280","author":"Long","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nano.2025.102861_bb0120","doi-asserted-by":"crossref","first-page":"6361","DOI":"10.1038\/sj.onc.1209882","article-title":"Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase","volume":"25","author":"Avruch","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.nano.2025.102861_bb0125","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.cell.2010.02.024","article-title":"Ragulator-rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids","volume":"141","author":"Sancak","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.nano.2025.102861_bb0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.bbacli.2015.11.003","article-title":"The mTOR pathway in obesity driven gastrointestinal cancers: potential targets and clinical trials","volume":"5","author":"Malley","year":"2016","journal-title":"BBA Clin"},{"key":"10.1016\/j.nano.2025.102861_bb0135","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/ncb1183","article-title":"Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive","volume":"6","author":"Jacinto","year":"2004","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.nano.2025.102861_bb0140","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1038\/onc.2016.363","article-title":"mTORC1 and mTORC2 in cancer and the tumor microenvironment","volume":"36","author":"Kim","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.nano.2025.102861_bb0145","doi-asserted-by":"crossref","first-page":"e395","DOI":"10.14694\/EdBook_AM.2013.33.e395","article-title":"Targeting the PI3K\/AKT\/mTOR pathway: biomarkers of success and tribulation","volume":"33","author":"Owonikoko","year":"2013","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.nano.2025.102861_bb0150","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.3816\/CBC.2010.s.017","article-title":"Biomarkers and patient selection for PI3K\/Akt\/mTOR targeted therapies: current status and future directions","volume":"10","author":"Bartlett","year":"2010","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.nano.2025.102861_bb0155","first-page":"33","article-title":"Pharmacodynamic biomarker development for PI3K pathway therapeutics","volume":"7","author":"Josephs","year":"2015","journal-title":"Transl Oncogenomics"},{"key":"10.1016\/j.nano.2025.102861_bb0160","doi-asserted-by":"crossref","first-page":"12261","DOI":"10.3748\/wjg.v21.i43.12261","article-title":"Targeting the PI3K\/Akt signaling pathway in gastric carcinoma: a reality for personalized medicine?","volume":"21","author":"Singh","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.nano.2025.102861_bb0165","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1002\/jcp.29333","article-title":"Role of regulatory miRNAs of the PI3K\/AKT\/mTOR signaling in the pathogenesis of hepatocellular carcinoma","volume":"235","author":"Rahmani","year":"2020","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.nano.2025.102861_bb0170","first-page":"2941","article-title":"Measuring symptoms in gastrointestinal cancer: a systematic review of assessment instruments","volume":"22","author":"Pullmer","year":"2014","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.nano.2025.102861_bb0175","doi-asserted-by":"crossref","first-page":"169","DOI":"10.6004\/jnccn.2025.0022","article-title":"Gastric cancer, version 2.2025, NCCN clinical practice guidelines in oncology","volume":"23","author":"Ajani","year":"2025","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.nano.2025.102861_bb0180","series-title":"National Comprehensive Cancer Network","year":"2025"},{"key":"10.1016\/j.nano.2025.102861_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2021.10.006","article-title":"Antibody drug conjugates in gastrointestinal cancer: from lab to clinical development","volume":"340","author":"Singh","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2025.102861_bb0190","article-title":"Antibody-drug conjugate combinations in cancer treatment: clinical efficacy and clinical study perspectives","volume":"16","author":"Shi","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.nano.2025.102861_bb0195","first-page":"167","article-title":"Immunotherapy in gastrointestinal cancers: current insights","volume":"17","author":"Jiang","year":"2025","journal-title":"Clin Pharmacol"},{"key":"10.1016\/j.nano.2025.102861_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14174201","article-title":"Immune checkpoint inhibitors for gastrointestinal malignancies: an update","volume":"14","author":"DeCarli","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.nano.2025.102861_bb0205","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jconrel.2015.09.067","article-title":"Novel delivery approaches for cancer therapeutics","volume":"219","author":"Mitra","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2025.102861_bb0210","doi-asserted-by":"crossref","first-page":"365","DOI":"10.4103\/jcrt.JCRT_297_18","article-title":"Evaluation of efficacy and safety of apatinib treatment in advanced gastric cancer","volume":"15","author":"Yang","year":"2019","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.nano.2025.102861_bb0215","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0378-5173(00)00617-7","article-title":"Solubilization of rapamycin","volume":"213","author":"Simamora","year":"2001","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2025.102861_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1366061","article-title":"Pharmacological mTOR inhibitors in ameliorating Alzheimer\u2019s disease: current review and perspectives","volume":"15","author":"Xie","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.nano.2025.102861_bb0225","first-page":"5","article-title":"Targeting the PI3K\/Akt\/mTOR signaling pathway: applications of nanotechnology","author":"Serej","year":"2018","journal-title":"Crescent Journal of Medical & Biological Sciences"},{"key":"10.1016\/j.nano.2025.102861_bb0230","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3390\/biom10010105","article-title":"Phytochemicals and gastrointestinal cancer: cellular mechanisms and effects to change cancer progression","volume":"10","author":"Al-Ishaq","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.nano.2025.102861_bb0235","doi-asserted-by":"crossref","first-page":"9951","DOI":"10.1002\/fsn3.4534","article-title":"The therapeutic effects of bioactive compounds on colorectal Cancer via PI3K\/Akt\/mTOR signaling pathway: a critical review","volume":"12","author":"Demir","year":"2024","journal-title":"Food Sci Nutr"},{"key":"10.1016\/j.nano.2025.102861_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodchem.2023.136438","article-title":"Impact of nanotechnology on the oral delivery of phyto-bioactive compounds","volume":"424","author":"Nsairat","year":"2023","journal-title":"Food Chem"},{"key":"10.1016\/j.nano.2025.102861_bb0245","doi-asserted-by":"crossref","DOI":"10.3390\/ph17030329","article-title":"Lipid-based nanoparticles in delivering bioactive compounds for improving therapeutic efficacy","volume":"17","author":"Patel","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.nano.2025.102861_bb0250","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev.bioeng.9.060906.152025","article-title":"Nanotechnology applications in cancer","volume":"9","author":"Nie","year":"2007","journal-title":"Annu Rev Biomed Eng"},{"key":"10.1016\/j.nano.2025.102861_bb0255","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s12032-025-02602-x","article-title":"Nanotechnology-based biomedical devices in the cancer diagnostics and therapy","volume":"42","author":"Tantray","year":"2025","journal-title":"Med Oncol"},{"key":"10.1016\/j.nano.2025.102861_bb0260","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.3390\/ijms12053303","article-title":"Nanomedicine: application areas and development prospects","volume":"12","author":"Boulaiz","year":"2011","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2025.102861_bb0265","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1166\/jbn.2014.1816","article-title":"The role of nanotechnology in gastrointestinal cancer","volume":"10","author":"Vyas","year":"2014","journal-title":"J Biomed Nanotechnol"},{"key":"10.1016\/j.nano.2025.102861_bb0270","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/mt.2014.96","article-title":"Nano-polypharmacy to treat tumors: coencapsulation of drug combinations using nanoparticle technology","volume":"22","author":"Alexis","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.nano.2025.102861_bb0275","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.addr.2016.04.025","article-title":"Challenges and strategies in anti-cancer nanomedicine development: an industry perspective","volume":"108","author":"Hare","year":"2017","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2025.102861_bb0280","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.2147\/IJN.S254574","article-title":"Nanotechnology-based targeting of mTOR signaling in cancer","author":"Yoon","year":"2020","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2025.102861_bb0285","doi-asserted-by":"crossref","first-page":"912","DOI":"10.3762\/bjnano.14.75","article-title":"Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics","volume":"14","author":"Kumari","year":"2023","journal-title":"Beilstein Journal of Nanotechnology"},{"key":"10.1016\/j.nano.2025.102861_bb0290","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1517\/14712598.8.8.1063","article-title":"Biofunctionalized targeted nanoparticles for therapeutic applications","volume":"8","author":"Wang","year":"2008","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.nano.2025.102861_bb0295","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13101719","article-title":"Green metallic nanoparticles for cancer therapy: evaluation models and cancer applications","volume":"13","author":"Tinajero-Diaz","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2025.102861_bb0300","series-title":"Noble and Precious Metals-Properties, Nanoscale Effects and Applications","first-page":"15","article-title":"Band Structure, Morphology, Functionality, and Size-Dependent Properties of Metal Nanoparticles","author":"Adekoya","year":"2018"},{"key":"10.1016\/j.nano.2025.102861_bb0305","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1007\/s12011-020-02414-2","article-title":"Metal nanoparticles: a promising treatment for viral and Arboviral infections","volume":"199","author":"Maduray","year":"2021","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.nano.2025.102861_bb0310","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1080\/10717544.2022.2039804","article-title":"Metal nanoparticles as a promising technology in targeted cancer treatment","volume":"29","author":"Xu","year":"2022","journal-title":"Drug Deliv"},{"key":"10.1016\/j.nano.2025.102861_bb0315","article-title":"Selenium-containing nanomaterials for cancer treatment","volume":"1","author":"Li","year":"2020","journal-title":"Cell Rep Phys Sci"},{"key":"10.1016\/j.nano.2025.102861_bb0320","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1007\/s12010-021-03598-6","article-title":"A review on green synthesis, characterization and anticancer application of metallic nanoparticles","volume":"193","author":"Thakur","year":"2021","journal-title":"Appl Biochem Biotechnol"},{"key":"10.1016\/j.nano.2025.102861_bb0325","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.drudis.2017.08.006","article-title":"Zinc oxide nanoparticles: a promising nanomaterial for biomedical applications","volume":"22","author":"Mishra","year":"2017","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.nano.2025.102861_bb0330","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1080\/10717544.2022.2039804","article-title":"Metal nanoparticles as a promising technology in targeted cancer treatment","volume":"29","author":"Xu","year":"2022","journal-title":"Drug Deliv"},{"key":"10.1016\/j.nano.2025.102861_bb0335","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s11033-024-09598-z","article-title":"Recent advances in the therapeutic applications of selenium nanoparticles","volume":"51","author":"Ansari","year":"2024","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.nano.2025.102861_bb0340","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2217\/nnm-2017-0024","article-title":"Selenium nanoparticles: potential in cancer gene and drug delivery","volume":"12","author":"Maiyo","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2025.102861_bb0345","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.biopha.2018.12.146","article-title":"Therapeutic applications of selenium nanoparticles","volume":"111","author":"Khurana","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.nano.2025.102861_bb0350","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/jat.4499","article-title":"Toxicological effects of selenium nanoparticles in laboratory animals: a review","volume":"44","author":"Ryabova","year":"2024","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.nano.2025.102861_bb0355","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s13237-019-00303-1","article-title":"Selenium nanoparticles are less toxic than inorganic and organic selenium to mice in vivo","volume":"62","author":"Bhattacharjee","year":"2019","journal-title":"Nucleus"},{"key":"10.1016\/j.nano.2025.102861_bb0360","first-page":"59","article-title":"Toxicity evaluation of selenium nanoparticles in early life stages of zebrafish","volume":"10","author":"Ravanshad","year":"2025","journal-title":"Nanomedicine Research Journal"},{"key":"10.1016\/j.nano.2025.102861_bb0365","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.2174\/1871520622666220215122756","article-title":"Application of selenium nanoparticles in localized drug targeting for cancer therapy","volume":"22","author":"Nath","year":"2022","journal-title":"Anti-Cancer Agents Med Chem-Anti-Cancer Agents"},{"key":"10.1016\/j.nano.2025.102861_bb0370","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1039\/D1MA00639H","article-title":"Selenium nanoparticles: a review on synthesis and biomedical applications","volume":"3","author":"Bisht","year":"2022","journal-title":"Materials Advances"},{"key":"10.1016\/j.nano.2025.102861_bb0375","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.biopha.2018.12.146","article-title":"Therapeutic applications of selenium nanoparticles","volume":"111","author":"Khurana","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.nano.2025.102861_bb0380","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.nano.2025.102861_bb0385","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2147\/JHC.S285726","article-title":"Elucidating the molecular basis of Sorafenib resistance in HCC: current findings and future directions","volume":"8","author":"Fornari","year":"2021","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.nano.2025.102861_bb0390","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120675","article-title":"Selenium nanoparticles overcomes sorafenib resistance in thioacetamide induced hepatocellular carcinoma in rats by modulation of mTOR, NF-\u03baB pathways and LncRNA-AF085935\/GPC3 axis","volume":"303","author":"Al-Noshokaty","year":"2022","journal-title":"Life Sci"},{"key":"10.1016\/j.nano.2025.102861_bb0395","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/IJN.S295053","article-title":"Biomedical potential of plant-based selenium nanoparticles: a comprehensive review on therapeutic and mechanistic aspects","author":"Ikram","year":"2021","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2025.102861_bb0400","doi-asserted-by":"crossref","first-page":"8125","DOI":"10.3390\/molecules28248125","article-title":"Selenium nanoparticles: green synthesis and biomedical application","volume":"28","author":"Mikhailova","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.nano.2025.102861_bb0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-014-0028-6","article-title":"Plants and microbes assisted selenium nanoparticles: characterization and application","volume":"12","author":"Husen","year":"2014","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.nano.2025.102861_bb0410","series-title":"Sources of green nanomaterials green Nanoarchitectonics","first-page":"27","author":"Manjceevan","year":"2022"},{"key":"10.1016\/j.nano.2025.102861_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154014","article-title":"Biosynthesis and cytotoxic effect of silymarin-functionalized selenium nanoparticles induced autophagy mediated cellular apoptosis via downregulation of PI3K\/Akt\/mTOR pathway in gastric cancer","volume":"99","author":"Mi","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.nano.2025.102861_bb0420","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-022-01576-6","article-title":"Biologically synthesized black ginger-selenium nanoparticle induces apoptosis and autophagy of AGS gastric cancer cells by suppressing the PI3K\/Akt\/mTOR signaling pathway","volume":"20","author":"Wang","year":"2022","journal-title":"J Nanobiotechnol"},{"key":"10.1016\/j.nano.2025.102861_bb0425","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00217-014-2306-9","article-title":"Ultrasonic extraction and structural identification of polysaccharides from Prunella vulgaris and its antioxidant and antiproliferative activities","volume":"240","author":"Li","year":"2015","journal-title":"Eur Food Res Technol"},{"key":"10.1016\/j.nano.2025.102861_bb0430","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.ijbiomac.2019.07.031","article-title":"Selenium nanoparticles fabricated in laminarin polysaccharides solutions exert their cytotoxicities in HepG2 cells by inhibiting autophagy and promoting apoptosis","volume":"137","author":"Cui","year":"2019","journal-title":"Int J Biol Macromol"},{"issue":"Pt 3","key":"10.1016\/j.nano.2025.102861_bb0435","article-title":"Construction and anti-pancreatic cancer activity of selenium nanoparticles stabilized by Prunella vulgaris polysaccharide","volume":"278","author":"Zhang","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.nano.2025.102861_bb0440","doi-asserted-by":"crossref","first-page":"8996","DOI":"10.7150\/thno.45413","article-title":"Silver nanoparticles: synthesis, medical applications and biosafety","volume":"10","author":"Xu","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.nano.2025.102861_bb0445","first-page":"461","article-title":"Antimicrobial activity of silver nanoparticles nanoparticles in pharmacotherapy","author":"Kailasa","year":"2019","journal-title":"Elsevier"},{"key":"10.1016\/j.nano.2025.102861_bb0450","doi-asserted-by":"crossref","first-page":"6341","DOI":"10.1016\/j.biomaterials.2009.08.008","article-title":"Antiangiogenic properties of silver nanoparticles","volume":"30","author":"Gurunathan","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2025.102861_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2021.112254","article-title":"Exploring silver nanoparticles for cancer therapy and diagnosis","volume":"210","author":"Miranda","year":"2022","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.nano.2025.102861_bb0460","series-title":"Silver Nanoparticles as Multi-Functional Drug Delivery Systems","author":"Ivanova","year":"2018"},{"key":"10.1016\/j.nano.2025.102861_bb0465","doi-asserted-by":"crossref","DOI":"10.3390\/nano11040964","article-title":"Silver nanoparticles as carriers of anticancer drugs for efficient target treatment of cancer cells","volume":"11","author":"Gomes","year":"2021","journal-title":"Nanomaterials (Basel)"},{"key":"10.1016\/j.nano.2025.102861_bb0470","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10112792","article-title":"Biomedical applications of plant extract-synthesized silver nanoparticles","volume":"10","author":"Simon","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.nano.2025.102861_bb0475","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/8409718","article-title":"Phytochemical study on antioxidant and antiproliferative activities of Moroccan Caralluma europaea extract and its bioactive compound classes","volume":"2020","author":"Amrati","year":"2020","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.nano.2025.102861_bb0480","article-title":"Antioxidant activity and lipoxygenase inhibitory effect of Caralluma arabica and related polyphenolic constituents","volume":"2014","author":"Khasawneh","year":"2014","journal-title":"Am J Plant Sci"},{"key":"10.1016\/j.nano.2025.102861_bb0485","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/ad26d9","article-title":"Caralluma pauciflora based ag-NPs activate ROS-induced apoptosis through down-regulation of AKT, mTOR and pI3K signaling in human gastric cancer (AGS) cells","volume":"35","author":"Navaneethan","year":"2024","journal-title":"Nanotechnology"},{"key":"10.1016\/j.nano.2025.102861_bb0490","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1007\/s12011-020-02463-7","article-title":"Green synthesized silver nanoparticles-mediated cytotoxic effect in colorectal cancer cells: NF-\u03baB signal induced apoptosis through autophagy","volume":"199","author":"Akter","year":"2021","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.nano.2025.102861_bb0495","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s12032-024-02330-8","article-title":"Probiotic-derived silver nanoparticles target mTOR\/MMP-9\/BCL-2\/dependent AMPK activation for hepatic cancer treatment","volume":"41","author":"Elmetwalli","year":"2024","journal-title":"Med Oncol"},{"key":"10.1016\/j.nano.2025.102861_bb0500","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.3390\/cancers12082099","article-title":"Oxidative stress and apoptotic responses elicited by nostoc-synthesized silver nanoparticles against different cancer cell lines","volume":"12","author":"Hamida","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.nano.2025.102861_bb0505","doi-asserted-by":"crossref","first-page":"S309","DOI":"10.21037\/tcr.2017.03.53","article-title":"Exploring gold nanoparticle interactions with proteins and the tumor microenvironment in biological systems","volume":"6","author":"Tian","year":"2017","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.nano.2025.102861_bb0510","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.2217\/nnm.14.219","article-title":"Gold nanoparticle surface functionalization: a necessary requirement in the development of novel nanotherapeutics","volume":"10","author":"Nicol","year":"2015","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.nano.2025.102861_bb0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/acs.molpharmaceut.8b00810","article-title":"Gold nanoparticles in Cancer treatment","volume":"16","author":"Sztandera","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2025.102861_bb0520","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1021\/acs.molpharmaceut.8b00810","article-title":"Gold nanoparticles in cancer treatment","volume":"16","author":"Sztandera","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2025.102861_bb0525","first-page":"1","article-title":"Ultrasound assisted green synthesis of lignosulfonate-gold nanocomposite (LS-Au NPs): the study of its application in the Suzuki\u2013Miyaura coupling reactions and its application for the treatment of gastric cancer","author":"Wang","year":"2025","journal-title":"J Inorg Organomet Polym Mater"},{"key":"10.1016\/j.nano.2025.102861_bb0530","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1038\/s41388-021-01811-8","article-title":"Antibody-based cancer therapy","volume":"40","author":"Goydel","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.nano.2025.102861_bb0535","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5876-11-307","article-title":"Trastuzumab mediates antibody-dependent cell-mediated cytotoxicity and phagocytosis to the same extent in both adjuvant and metastatic HER2\/neu breast cancer patients","volume":"11","author":"Petricevic","year":"2013","journal-title":"J Transl Med"},{"key":"10.1016\/j.nano.2025.102861_bb0540","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1038\/sj.onc.1206779","article-title":"Biologic and therapeutic role of HER2 in cancer","volume":"22","author":"M\u00e9nard","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.nano.2025.102861_bb0545","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","article-title":"Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial","volume":"376","author":"Bang","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.nano.2025.102861_bb0550","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ccr.2007.08.030","article-title":"A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer","volume":"12","author":"Berns","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.nano.2025.102861_bb0555","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1158\/1078-0432.CCR-13-2769","article-title":"Targeting PI3K\/mTOR overcomes resistance to HER2-targeted therapy independent of feedback activation of AKT","volume":"20","author":"O\u2019Brien","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nano.2025.102861_bb0560","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.nano.2018.05.019","article-title":"HER2-targeted gold nanoparticles potentially overcome resistance to trastuzumab in gastric cancer","volume":"14","author":"Kubota","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2025.102861_bb0565","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/j.ijrobp.2003.11.041","article-title":"Review of epidermal growth factor receptor biology","volume":"59","author":"Herbst","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.nano.2025.102861_bb0570","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/abbs\/gmy046","article-title":"Photothermal treatment with EGFRmAb-AuNPs induces apoptosis in hypopharyngeal carcinoma cells via PI3K\/AKT\/mTOR and DNA damage response pathways","volume":"50","author":"Zhang","year":"2018","journal-title":"Acta Biochim Biophys Sin Shanghai"},{"key":"10.1016\/j.nano.2025.102861_bb0575","first-page":"189","article-title":"Apoptosis in human liver carcinoma caused by gold nanoparticles in combination with carvedilol is mediated via modulation of MAPK\/Akt\/mTOR pathway and EGFR\/FAAD proteins","volume":"52","author":"De Araujo","year":"2018","journal-title":"Int J Oncol"},{"key":"10.1016\/j.nano.2025.102861_bb0580","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/magnetochemistry6030030","article-title":"Magnetic nanoparticles for biomedical purposes: modern trends and prospects","volume":"6","author":"Shabatina","year":"2020","journal-title":"Magnetochemistry"},{"key":"10.1016\/j.nano.2025.102861_bb0585","first-page":"1","article-title":"The use of iron oxide nanoparticles for pancreatic cancer therapy","volume":"1","author":"Malekigorji","year":"2014","journal-title":"Journal of Nanomedicine Research"},{"key":"10.1016\/j.nano.2025.102861_bb0590","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1007\/s12011-022-03221-7","article-title":"Antitumor activity of chitosan-coated Iron oxide nanocomposite against hepatocellular carcinoma in animal models","volume":"201","author":"Badawy","year":"2023","journal-title":"Biol Trace Elem Res"},{"key":"10.1016\/j.nano.2025.102861_bb0595","doi-asserted-by":"crossref","DOI":"10.3390\/cells9041015","article-title":"Iron oxide nanoparticle-induced autophagic flux is regulated by interplay between p53-mTOR axis and Bcl-2 signaling in hepatic cells","volume":"9","author":"Uzhytchak","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.nano.2025.102861_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.genrep.2023.101818","article-title":"Evaluation of the effect of iron oxide nanoparticles functionalized by glucose and conjugated with coumarin (Fe3O4@ Glu-Coumarin NPs) on the expression of CASP8, CASP9, p53, mTOR1, and MAPK1 genes in liver cancer cell line","volume":"33","author":"Shokrollahi","year":"2023","journal-title":"Gene Reports"},{"key":"10.1016\/j.nano.2025.102861_bb0605","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.3390\/cancers13184570","article-title":"Recent advances in zinc oxide nanoparticles (ZnO NPs) for cancer diagnosis, target drug delivery, and treatment","volume":"13","author":"Anjum","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.nano.2025.102861_bb0610","first-page":"67","article-title":"Biomedical applications of zinc oxide nanomaterials in cancer treatment: a review","volume":"1","author":"Malhotra","year":"2016","journal-title":"SCIREA Journal of Chemistry"},{"key":"10.1016\/j.nano.2025.102861_bb0615","doi-asserted-by":"crossref","DOI":"10.1002\/cbf.3909","article-title":"ZnO nanomaterials target mitochondrial apoptosis and mitochondrial autophagy pathways in cancer cells","volume":"42","author":"Li","year":"2024","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/j.nano.2025.102861_bb0620","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1016\/j.arabjc.2020.03.028","article-title":"Piperine loaded zinc oxide nanocomposite inhibits the PI3K\/AKT\/mTOR signaling pathway via attenuating the development of gastric carcinoma: in vitro and in vivo studies","volume":"13","author":"Yang","year":"2020","journal-title":"Arab J Chem"},{"key":"10.1016\/j.nano.2025.102861_bb0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.jksus.2021.101641","article-title":"Green synthesized zinc oxide\/neodymium nanocomposites from Avaram senna flower extract induces apoptosis in gastric cancer ags cell line through inhibition of the PI3K\/AKT\/mTOR signaling pathway","volume":"33","author":"Sun","year":"2021","journal-title":"Journal of King Saud University-Science"},{"key":"10.1016\/j.nano.2025.102861_bb0630","article-title":"Zinc-doped copper oxide nanocomposites inhibit the growth of pancreatic cancer by inducing autophagy through AMPK\/mTOR pathway","volume":"10","author":"Li","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.nano.2025.102861_bb0635","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1039\/C9CS00283A","article-title":"The versatile biomedical applications of bismuth-based nanoparticles and composites: therapeutic, diagnostic, biosensing, and regenerative properties","volume":"49","author":"Shahbazi","year":"2020","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.nano.2025.102861_bb0640","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.ejmp.2016.10.015","article-title":"First proof of bismuth oxide nanoparticles as efficient radiosensitisers on highly radioresistant cancer cells","volume":"32","author":"Stewart","year":"2016","journal-title":"Phys Med"},{"key":"10.1016\/j.nano.2025.102861_bb0645","doi-asserted-by":"crossref","first-page":"13016","DOI":"10.1021\/acsnano.0c04375","article-title":"Suppressing the radiation-induced corrosion of bismuth nanoparticles for enhanced synergistic cancer radiophototherapy","volume":"14","author":"Zhou","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2025.102861_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2021.103607","article-title":"Regulation of the PI3K\/AKT\/mTOR signaling pathway with synthesized bismuth oxide nanoparticles from ginger (Zingiber officinale) extract: mitigating the proliferation of colorectal cancer cells","volume":"15","author":"Zhou","year":"2022","journal-title":"Arab J Chem"},{"key":"10.1016\/j.nano.2025.102861_bb0655","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1039\/c3tb20990c","article-title":"Recent trends in the use of lipidic nanoparticles as pharmaceutical carriers for cancer therapy and diagnostics","volume":"1","author":"Mussi","year":"2013","journal-title":"J Mater Chem B"},{"key":"10.1016\/j.nano.2025.102861_bb0660","series-title":"An Overview of Lipid Nanoparticles for Drug Targeting","author":"Reddy","year":"2022"},{"key":"10.1016\/j.nano.2025.102861_bb0665","doi-asserted-by":"crossref","first-page":"638","DOI":"10.3390\/nano9040638","article-title":"Lipid-based nanoparticles: application and recent advances in cancer treatment","volume":"9","author":"Garc\u00eda-Pinel","year":"2019","journal-title":"Nanomaterials"},{"key":"10.1016\/j.nano.2025.102861_bb0670","article-title":"Passive and active targeting in cancer therapy by liposomes and lipid nanoparticles","volume":"34","author":"Alavi","year":"2019","journal-title":"Drug Metab Pers Ther"},{"key":"10.1016\/j.nano.2025.102861_bb0675","article-title":"Current trends in the development of liposomes for chemotherapeutic drug delivery","volume":"87","author":"Kumbham","year":"2023","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.nano.2025.102861_bb0680","doi-asserted-by":"crossref","first-page":"6547","DOI":"10.3390\/ijms22126547","article-title":"Basic methods for preparation of liposomes and studying their interactions with different compounds, with the emphasis on polyphenols","volume":"22","author":"\u0160turm","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2025.102861_bb0685","doi-asserted-by":"crossref","first-page":"3041969","DOI":"10.1155\/2021\/3041969","article-title":"Investigating the application of liposomes as drug delivery systems for the diagnosis and treatment of cancer","volume":"2021","author":"Allahou","year":"2021","journal-title":"International journal of biomaterials"},{"key":"10.1016\/j.nano.2025.102861_bb0690","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and challenges of liposome assisted drug delivery","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.nano.2025.102861_bb0695","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09394","article-title":"Liposomes: structure, composition, types, and clinical applications","volume":"8","author":"Nsairat","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.nano.2025.102861_bb0700","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11010022","article-title":"Current trends in cancer nanotheranostics: metallic, polymeric, and lipid-based systems","volume":"11","author":"Silva","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2025.102861_bb0705","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/1389557518666180903150928","article-title":"New trends in liposome-based drug delivery in colorectal cancer","volume":"19","author":"Krajewska","year":"2019","journal-title":"Mini Rev Med Chem"},{"issue":"23","key":"10.1016\/j.nano.2025.102861_bb0710","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.4161\/cc.22926","article-title":"Rapamycin in lipoproteins for enhanced delivery","volume":"11","author":"Cho","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.nano.2025.102861_bb0715","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2147\/IJN.S270939","article-title":"Delivery of rapamycin by liposomes synergistically enhances the chemotherapy effect of 5-fluorouracil on colorectal cancer","author":"Chen","year":"2021","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2025.102861_bb0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120187","article-title":"Metabolic modulation via mTOR pathway and anti-angiogenesis remodels tumor microenvironment using PD-L1-targeting codelivery","volume":"255","author":"Chen","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2025.102861_bb0725","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/cmdc.202000131","article-title":"Antitumour anthracyclines: Progress and perspectives","volume":"15","author":"Martins-Teixeira","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.nano.2025.102861_bb0730","article-title":"Investigation of the cytotoxic and antiproliferative effects of liposomal Daunorubicin on human colorectal cancer (HCT116) cell line","volume":"23","author":"Hadi-al-Ward","year":"2024","journal-title":"IJ Pharm Res"},{"key":"10.1016\/j.nano.2025.102861_bb0735","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jconrel.2015.10.037","article-title":"Cytotoxicity of PEGylated liposomes co-loaded with novel pro-apoptotic drug NCL-240 and the MEK inhibitor cobimetinib against colon carcinoma in vitro","volume":"220","author":"Sriraman","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2025.102861_bb0740","doi-asserted-by":"crossref","DOI":"10.1088\/1748-605X\/abdb08","article-title":"Glucocorticoid receptor-targeted liposomal delivery system for delivering small molecule ESC8 and anti-miR-Hsp90 gene construct to combat colon cancer","volume":"16","author":"Jinka","year":"2021","journal-title":"Biomed Mater"},{"key":"10.1016\/j.nano.2025.102861_bb0745","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.canlet.2011.07.010","article-title":"Targeting the ceramide system in cancer","volume":"332","author":"Henry","year":"2013","journal-title":"Cancer Lett"},{"key":"10.1016\/j.nano.2025.102861_bb0750","doi-asserted-by":"crossref","first-page":"284","DOI":"10.2174\/157489211796957838","article-title":"Ceramide in chemotherapy of tumors","volume":"6","author":"Dimanche-Boitrel","year":"2011","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"10.1016\/j.nano.2025.102861_bb0755","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/bj20021878","article-title":"Killing tumours by ceramide-induced apoptosis: a critique of available drugs","volume":"371","author":"Radin","year":"2003","journal-title":"Biochem J"},{"key":"10.1016\/j.nano.2025.102861_bb0760","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145195","article-title":"Preclinical evaluation of liposomal C8 ceramide as a potent anti-hepatocellular carcinoma agent","volume":"11","author":"Lv","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2025.102861_bb0765","doi-asserted-by":"crossref","first-page":"540","DOI":"10.2174\/1389557033487854","article-title":"Plant-derived triterpenoids as potential antineoplastic agents","volume":"3","author":"Setzer","year":"2003","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/j.nano.2025.102861_bb0770","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nrc2129","article-title":"Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer","volume":"7","author":"Liby","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.nano.2025.102861_bb0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155777","article-title":"Chemotherapeutic potential of lupeol against cancer in pre-clinical model: a systematic review and meta-analysis","volume":"132","author":"Fatma","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.nano.2025.102861_bb0780","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/10717544.2021.1905749","article-title":"In vitro and in vivo antitumor effects of lupeol-loaded galactosylated liposomes","volume":"28","author":"Zhang","year":"2021","journal-title":"Drug Deliv"},{"key":"10.1016\/j.nano.2025.102861_bb0785","doi-asserted-by":"crossref","first-page":"8068","DOI":"10.2174\/0929867327666201109122025","article-title":"mTOR targeted cancer chemoprevention by flavonoids","volume":"28","author":"Badar Ul","year":"2021","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.nano.2025.102861_bb0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111218","article-title":"Alkaloid-based modulators of the PI3K\/Akt\/mTOR pathway for cancer therapy: understandings from pharmacological point of view","volume":"402","author":"Mokhfi","year":"2024","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.nano.2025.102861_bb0795","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.taap.2013.05.031","article-title":"Isoliquiritigenin induces growth inhibition and apoptosis through downregulating arachidonic acid metabolic network and the deactivation of PI3K\/Akt in human breast cancer","volume":"272","author":"Li","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.nano.2025.102861_bb0800","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1159\/000430372","article-title":"Isoliquiritigenin inhibits interferon-\u03b3-inducible genes expression in hepatocytes through down-regulating activation of JAK1\/STAT1, IRF3\/MyD88, ERK\/MAPK, JNK\/MAPK and PI3K\/Akt signaling pathways","volume":"37","author":"Wu","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.nano.2025.102861_bb0805","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijpharm.2019.03.034","article-title":"Preparation, in vitro and in vivo evaluation of isoliquiritigenin-loaded TPGS modified proliposomes","volume":"563","author":"Liu","year":"2019","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2025.102861_bb0810","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1080\/21691401.2020.1825092","article-title":"The effects and mechanisms of isoliquiritigenin loaded nanoliposomes regulated AMPK\/mTOR mediated glycolysis in colorectal cancer","volume":"48","author":"Wang","year":"2020","journal-title":"Artificial Cells, Nanomedicine, and Biotechnology"},{"key":"10.1016\/j.nano.2025.102861_bb0815","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26237368","article-title":"Berberine as a potential anticancer agent: a comprehensive review","volume":"26","author":"Rauf","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.nano.2025.102861_bb0820","article-title":"Nanotechnology-based strategies for Berberine delivery system in cancer treatment: pulling strings to keep Berberine in power","volume":"7","author":"Iqbal","year":"2020","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.nano.2025.102861_bb0825","doi-asserted-by":"crossref","first-page":"7417","DOI":"10.2147\/IJN.S434840","article-title":"Formulation of deformable liponiosomal hybrid of Repaglinide: in vitro characterization and evaluation of the anti-diabetic effect","author":"Abdelwahab","year":"2023","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2025.102861_bb0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123511","article-title":"Prospects of new targeted nanotherapy combining liponiosomes with berberine to combat colorectal cancer development: an in vivo experimental model","volume":"647","author":"Ibrahim","year":"2023","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2025.102861_bb0835","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ajps.2013.07.009","article-title":"Application of cationic liposomes for delivery of nucleic acids","volume":"8","author":"Shim","year":"2013","journal-title":"Asian journal of pharmaceutical sciences"},{"key":"10.1016\/j.nano.2025.102861_bb0840","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.70002","article-title":"Polymers for mRNA delivery","volume":"17","author":"Wang","year":"2025","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"10.1016\/j.nano.2025.102861_bb0845","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1038\/s41598-023-31560-5","article-title":"The effect of 1, 2-dioleoyl-3-trimethylammonium propane (DOTAP) addition on the physical characteristics of \u03b2-ionone liposomes","volume":"13","author":"Miatmoko","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.nano.2025.102861_bb0850","doi-asserted-by":"crossref","first-page":"2100194","DOI":"10.1002\/marc.202100194","article-title":"Recent progress in polymer cubosomes and hexosomes","volume":"42","author":"Chen","year":"2021","journal-title":"Macromol Rapid Commun"},{"key":"10.1016\/j.nano.2025.102861_bb0855","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11041114","article-title":"Cubosomes in drug delivery-a comprehensive review on its structural components, Preparation Techniques and Therapeutic Applications","volume":"11","author":"Sivadasan","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.nano.2025.102861_bb0860","doi-asserted-by":"crossref","DOI":"10.1016\/j.colcom.2021.100561","article-title":"Cubosomes in cancer drug delivery: a review","volume":"46","author":"Varghese","year":"2022","journal-title":"Colloid Interface Sci Commun"},{"issue":"Pt 1","key":"10.1016\/j.nano.2025.102861_bb0865","article-title":"The cubosome-based nanoplatforms in cancer therapy: seeking new paradigms for cancer theranostics","volume":"237","author":"Gowda","year":"2023","journal-title":"Environ Res"},{"key":"10.1016\/j.nano.2025.102861_bb0870","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14030600","article-title":"Development, Therapeutic Evaluation and Theranostic Applications of Cubosomes on Cancers: An Updated Review","volume":"14","author":"Almoshari","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2025.102861_bb0875","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-018-4727-5","article-title":"Targeting colorectal cancer cell metabolism through development of cisplatin and metformin nano-cubosomes","volume":"18","author":"Saber","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.nano.2025.102861_bb0880","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10070238","article-title":"Micelles structure development as a strategy to improve smart cancer therapy","volume":"10","author":"Hanafy","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.nano.2025.102861_bb0885","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/nbm.1011","article-title":"Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging","volume":"19","author":"Mulder","year":"2006","journal-title":"NMR Biomed"},{"key":"10.1016\/j.nano.2025.102861_bb0890","series-title":"Nanoformulation strategies for Cancer treatment","first-page":"65","article-title":"Polymeric nanoparticles for potential drug delivery applications in cancer","author":"Fatima","year":"2021"},{"key":"10.1016\/j.nano.2025.102861_bb0895","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.actbio.2016.07.006","article-title":"Engineering of caveolae-specific self-micellizing anticancer lipid nanoparticles to enhance the chemotherapeutic efficacy of oxaliplatin in colorectal cancer cells","volume":"42","author":"Sundaramoorthy","year":"2016","journal-title":"Acta Biomater"},{"key":"10.1016\/j.nano.2025.102861_bb0900","series-title":"Solid lipid nanoparticles for anti-tumor drug delivery nanotechnology for cancer therapy","first-page":"741","author":"Wong","year":"2006"},{"key":"10.1016\/j.nano.2025.102861_bb0905","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4103\/1735-5362.235156","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages","volume":"13","author":"Ghasemiyeh","year":"2018","journal-title":"Res Pharm Sci"},{"key":"10.1016\/j.nano.2025.102861_bb0910","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0939-6411(00)00087-4","article-title":"Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art","volume":"50","author":"M\u00fcller","year":"2000","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.nano.2025.102861_bb0915","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.addr.2007.04.008","article-title":"Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles","volume":"59","author":"Wong","year":"2007","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2025.102861_bb0920","article-title":"Solid lipid nanoparticles: an effective lipid-based technology for cancer treatment","volume":"86","author":"Akanda","year":"2023","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.nano.2025.102861_bb0925","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14091759","article-title":"Two-in-one nanoparticle formulation to deliver a tyrosine kinase inhibitor and microrna for targeting metabolic reprogramming and mitochondrial dysfunction in gastric cancer","volume":"14","author":"Lo","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2025.102861_bb0930","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1080\/17425247.2024.2410949","article-title":"Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for the delivery of bioactives sourced from plants: part II - applications and preclinical advancements","volume":"21","author":"Fathi","year":"2024","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.nano.2025.102861_bb0935","doi-asserted-by":"crossref","first-page":"4875","DOI":"10.3748\/wjg.v17.i44.4875","article-title":"Inhibition of tumor angiogenesis by TTF1 from extract of herbal medicine","volume":"17","author":"Liu","year":"2011","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.nano.2025.102861_bb0940","first-page":"651","article-title":"TTF1-induced apoptosis of HepG-2 cells through a mitochondrial pathway","volume":"26","author":"Li","year":"2011","journal-title":"Oncol Rep"},{"key":"10.1016\/j.nano.2025.102861_bb0945","first-page":"1423","article-title":"TTF1-NP induces protective autophagy during apoptosis by inhibiting the Akt\/mTOR pathway and activating JNK in human liver cancer cells","volume":"39","author":"Zhang","year":"2018","journal-title":"Oncol Rep"},{"key":"10.1016\/j.nano.2025.102861_bb0950","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3892\/ol.2021.13011","article-title":"Progress on the study of the anticancer effects of artesunate","volume":"22","author":"Yang","year":"2021","journal-title":"Oncol Lett"},{"key":"10.1016\/j.nano.2025.102861_bb0955","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1007\/s11033-020-05669-z","article-title":"Artemisinin and its derivatives: a promising cancer therapy","volume":"47","author":"Kiani","year":"2020","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.nano.2025.102861_bb0960","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2024.111108","article-title":"Artesunate-loaded solid lipid nanoparticles resist esophageal squamous cell carcinoma by inducing Ferroptosis through inhibiting the AKT\/mTOR signaling","volume":"117","author":"Xia","year":"2024","journal-title":"Cell Signal"},{"key":"10.1016\/j.nano.2025.102861_bb0965","series-title":"Cancer nanotechnology: Methods and protocols","first-page":"163","article-title":"Polymeric Nanoparticles for Drug Delivery","author":"Chan","year":"2010"},{"key":"10.1016\/j.nano.2025.102861_bb0970","series-title":"Biopolymer-Based Composites","first-page":"221","article-title":"8 - nanoparticles for tumor targeting","author":"Jiang","year":"2017"},{"key":"10.1016\/j.nano.2025.102861_bb0975","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.msec.2015.11.067","article-title":"Polymeric nanoparticles for targeted drug delivery system for cancer therapy","volume":"60","author":"Masood","year":"2016","journal-title":"Mater Sci Eng C"},{"key":"10.1016\/j.nano.2025.102861_bb0980","doi-asserted-by":"crossref","first-page":"25","DOI":"10.37022\/jiaps.v9i1.575","article-title":"Polymeric nanoparticles\u2013a review","author":"Gillella","year":"2024","journal-title":"Journal of Innovations in Applied Pharmaceutical Science (JIAPS)"},{"key":"10.1016\/j.nano.2025.102861_bb0985","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.colsurfb.2014.03.017","article-title":"Overview of the preparation of organic polymeric nanoparticles for drug delivery based on gelatine, chitosan, poly(d,l-lactide-co-glycolic acid) and polyalkylcyanoacrylate","volume":"118","author":"Lai","year":"2014","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.nano.2025.102861_bb0990","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.2174\/1381612822666160510125718","article-title":"Alginate based Nanocarriers for drug delivery applications","volume":"22","author":"Jana","year":"2016","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.nano.2025.102861_bb0995","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.progpolymsci.2016.05.005","article-title":"Polymeric nanostructured materials for biomedical applications","volume":"60","author":"Tang","year":"2016","journal-title":"Prog Polym Sci"},{"key":"10.1016\/j.nano.2025.102861_bb1000","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3390\/nano10071403","article-title":"Polymeric nanoparticles for drug delivery: recent developments and future prospects","volume":"10","author":"Begines","year":"2020","journal-title":"Nanomaterials"},{"key":"10.1016\/j.nano.2025.102861_bb1005","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14081636","article-title":"Progress in polymeric micelles for drug delivery applications","volume":"14","author":"Kotta","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2025.102861_bb1010","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jconrel.2021.02.016","article-title":"Polymeric micelles in cancer therapy: state of the art","volume":"332","author":"Ghosh","year":"2021","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2025.102861_bb1015","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1021\/jm0602817","article-title":"Synthesis and anticancer activity of brefeldin a ester derivatives","volume":"49","author":"Anadu","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.nano.2025.102861_bb1020","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/cbdd.12154","article-title":"Synthesis and cytotoxic evaluation of acylated brefeldin a derivatives as potential anticancer agents","volume":"82","author":"He","year":"2013","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.nano.2025.102861_bb1025","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105800","article-title":"Brefeldin a delivery nanomicelles in hepatocellular carcinoma therapy: characterization, cytotoxic evaluation in vitro, and antitumor efficiency in vivo","volume":"172","author":"Zhang","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.nano.2025.102861_bb1030","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jconrel.2014.11.034","article-title":"Targeted therapy of colorectal neoplasia with rapamycin in peptide-labeled pegylated octadecyl lithocholate micelles","volume":"199","author":"Khondee","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2025.102861_bb1035","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112328","article-title":"The role of natural antioxidants in cisplatin-induced hepatotoxicity","volume":"144","author":"Abd Rashid","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"20230053","key":"10.1016\/j.nano.2025.102861_bb1040","article-title":"Enhanced apoptotic activity of Pluronic F127 polymer-encapsulated chlorogenic acid nanoparticles through the PI3K\/Akt\/mTOR signaling pathway in liver cancer cells and in vivo toxicity studies in zebrafish","volume":"23","author":"Alanazi","year":"2023","journal-title":"e-Polymers"},{"key":"10.1016\/j.nano.2025.102861_bb1045","doi-asserted-by":"crossref","first-page":"1907256","DOI":"10.1002\/smll.201907256","article-title":"Protein-based artificial nanosystems in cancer therapy","volume":"16","author":"Zhang","year":"2020","journal-title":"Small"},{"key":"10.1016\/j.nano.2025.102861_bb1050","doi-asserted-by":"crossref","first-page":"380","DOI":"10.2174\/1381612827666211102100118","article-title":"Recent advances in gelatin-based nanomedicine for targeted delivery of anti-Cancer drugs","volume":"28","author":"Raza","year":"2022","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.nano.2025.102861_bb1055","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1039\/D2BM01814D","article-title":"Camptothecin loaded casein nanosystem for tuning the therapeutic efficacy against highly metastatic triple-negative breast cancer cells","volume":"11","author":"Khatun","year":"2023","journal-title":"Biomater Sci"},{"key":"10.1016\/j.nano.2025.102861_bb1060","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.3109\/03639045.2015.1040415","article-title":"Coated biodegradable casein nanospheres: a valuable tool for oral drug delivery","volume":"41","author":"Spizzirri","year":"2015","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.nano.2025.102861_bb1065","first-page":"9285854","article-title":"Protein based nanostructures for drug delivery","volume":"2018","author":"Verma","year":"2018","journal-title":"J Pharm (Cairo)"},{"key":"10.1016\/j.nano.2025.102861_bb1070","doi-asserted-by":"crossref","DOI":"10.1007\/s11051-013-1581-x","article-title":"Biodegradable gelatin-based nanospheres as pH-responsive drug delivery systems","volume":"15","author":"Curcio","year":"2013","journal-title":"J Nanopart Res"},{"key":"10.1016\/j.nano.2025.102861_bb1075","series-title":"Casein Proteins: Structural and Functional Aspects Milk Proteins-from Structure to Biological Properties and Health Aspects","author":"Bhat","year":"2016"},{"key":"10.1016\/j.nano.2025.102861_bb1080","first-page":"226","article-title":"Polymeric nanoparticles in Cancer chemotherapy: a narrative review","volume":"51","author":"Yousefi Rizi","year":"2022","journal-title":"Iran J Public Health"},{"key":"10.1016\/j.nano.2025.102861_bb1085","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.1024143","article-title":"Polymeric nanoparticles-promising carriers for cancer therapy","volume":"10","author":"Xiao","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.nano.2025.102861_bb1090","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1080\/09205063.2024.2371186","article-title":"Nanospheres for curcumin delivery as a precision nanomedicine in cancer therapy","volume":"35","author":"Mahjoubin-Tehran","year":"2024","journal-title":"J Biomater Sci Polym Ed"},{"key":"10.1016\/j.nano.2025.102861_bb1095","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1002\/mc.23090","article-title":"Gemcitabine-induced epithelial-mesenchymal transition-like changes sustain chemoresistance of pancreatic cancer cells of mesenchymal-like phenotype","volume":"58","author":"El Amrani","year":"2019","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.nano.2025.102861_bb1100","doi-asserted-by":"crossref","first-page":"319","DOI":"10.2147\/IJN.S149196","article-title":"Overcoming tumor cell chemoresistance using nanoparticles: lysosomes are beneficial for (stearoyl) gemcitabine-incorporated solid lipid nanoparticles","author":"Chen","year":"2018","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2025.102861_bb1105","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1021\/acs.molpharmaceut.0c01225","article-title":"Combining gemcitabine-loaded macrophage-like nanoparticles and erlotinib for pancreatic cancer therapy","volume":"18","author":"Cai","year":"2021","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2025.102861_bb1110","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2021.105293","article-title":"Nimbolide-encapsulated PLGA nanoparticles induces mesenchymal-to-epithelial transition by dual inhibition of AKT and mTOR in pancreatic cancer stem cells","volume":"79","author":"Singh","year":"2022","journal-title":"Toxicol in Vitro"},{"key":"10.1016\/j.nano.2025.102861_bb1115","doi-asserted-by":"crossref","first-page":"1500731","DOI":"10.3389\/fphar.2024.1500731","article-title":"Enhanced tumor suppression in colorectal cancer via berberine-loaded PEG-PLGA nanoparticles","volume":"15","author":"Shen","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.nano.2025.102861_bb1120","doi-asserted-by":"crossref","first-page":"4310","DOI":"10.3390\/md13074310","article-title":"Multiple mechanisms of anti-cancer effects exerted by astaxanthin","volume":"13","author":"Zhang","year":"2015","journal-title":"Mar Drugs"},{"key":"10.1016\/j.nano.2025.102861_bb1125","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104689","article-title":"Astaxanthin anticancer effects are mediated through multiple molecular mechanisms: a systematic review","volume":"155","author":"Faraone","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.nano.2025.102861_bb1130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.tifs.2022.07.007","article-title":"Advances of astaxanthin-based delivery systems for precision nutrition","volume":"127","author":"Chen","year":"2022","journal-title":"Trends Food Sci Technol"},{"key":"10.1016\/j.nano.2025.102861_bb1135","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1021\/acs.jafc.8b06963","article-title":"Design of astaxanthin-loaded core\u2013shell nanoparticles consisting of chitosan oligosaccharides and poly (lactic-co-glycolic acid): enhancement of water solubility, stability, and bioavailability","volume":"67","author":"Liu","year":"2019","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.nano.2025.102861_bb1140","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12885-024-13401-4","article-title":"Astaxanthin-loaded PLGA nanoparticles inhibit survival of MKN-45 gastric cancer cell line by modulating JAK2\/STAT3\/mTOR\/PI3K pathway","volume":"25","author":"YektaKooshali","year":"2025","journal-title":"BMC Cancer"},{"key":"10.1016\/j.nano.2025.102861_bb1145","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1021\/nl2035354","article-title":"Delivery of multiple siRNAs using lipid-coated PLGA nanoparticles for treatment of prostate cancer","volume":"12","author":"Hasan","year":"2012","journal-title":"Nano Lett"},{"key":"10.1016\/j.nano.2025.102861_bb1150","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109022","article-title":"A review of PD-1\/PD-L1 siRNA delivery systems in immune T cells and cancer cells","volume":"111","author":"Barati","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.nano.2025.102861_bb1155","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.biopha.2018.11.105","article-title":"PD-1\/ PD-L1 blockade as a novel treatment for colorectal cancer","volume":"110","author":"Yaghoubi","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.nano.2025.102861_bb1160","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","article-title":"Immune checkpoint blockade in Cancer therapy","volume":"33","author":"Postow","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.nano.2025.102861_bb1165","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1002\/cam4.3739","article-title":"Bladder cancer cell-intrinsic PD-L1 signals promote mTOR and autophagy activation that can be inhibited to improve cytotoxic chemotherapy","volume":"10","author":"Zhang","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.nano.2025.102861_bb1170","doi-asserted-by":"crossref","first-page":"4940","DOI":"10.1021\/acs.molpharmaceut.9b00826","article-title":"PLGA nanoparticles Codelivering siRNAs against programmed cell death Protein-1 and its ligand gene for suppression of Colon tumor growth","volume":"16","author":"Kwak","year":"2019","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2025.102861_bb1175","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117580","article-title":"Dendritic cell therapy in cancer treatment; the state-of-the-art","volume":"254","author":"Sadeghzadeh","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/j.nano.2025.102861_bb1180","first-page":"2091","article-title":"Dendritic cells based immunotherapy","volume":"7","author":"Shang","year":"2017","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.nano.2025.102861_bb1185","doi-asserted-by":"crossref","first-page":"7624","DOI":"10.1073\/pnas.1817147116","article-title":"Nanobody-based CAR T cells that target the tumor microenvironment inhibit the growth of solid tumors in immunocompetent mice","volume":"116","author":"Xie","year":"2019","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.nano.2025.102861_bb1190","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e27234","article-title":"Black phosphorus-based nanoparticles induce liver cancer cell mitochondrial apoptosis and immune cell tumor infiltration for enhancing dendritic cell therapy","volume":"10","author":"Liao","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.nano.2025.102861_bb1195","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1359-6446(04)03276-3","article-title":"Dendrimers and dendritic polymers in drug delivery","volume":"10","author":"Gillies","year":"2005","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.nano.2025.102861_bb1200","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.progpolymsci.2013.07.005","article-title":"Dendrimer as nanocarrier for drug delivery","volume":"39","author":"Kesharwani","year":"2014","journal-title":"Prog Polym Sci"},{"key":"10.1016\/j.nano.2025.102861_bb1205","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.drudis.2016.09.013","article-title":"Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery","volume":"22","author":"Sharma","year":"2017","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.nano.2025.102861_bb1210","first-page":"142","article-title":"Dendrimers and their applications as novel drug delivery carriers","volume":"3","author":"Tripathy","year":"2013","journal-title":"Journal of Applied Pharmaceutical Science"},{"key":"10.1016\/j.nano.2025.102861_bb1215","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.2174\/138161210791920469","article-title":"Polymeric carriers for gene delivery: chitosan and poly(amidoamine) dendrimers","volume":"16","author":"Xu","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.nano.2025.102861_bb1220","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/25\/36\/365101","article-title":"Cationic poly(amidoamine) dendrimers induced cyto-protective autophagy in hepatocellular carcinoma cells","volume":"25","author":"Li","year":"2014","journal-title":"Nanotechnology"},{"key":"10.1016\/j.nano.2025.102861_bb1225","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2019.11.020","article-title":"Reverting chemoresistance of targeted agents by a ultrasoluble dendritic nanocapsule","volume":"317","author":"Hu","year":"2020","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2025.102861_bb1230","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3892\/or.2013.2283","article-title":"Poly(amido amine) is an ideal carrier of miR-7 for enhancing gene silencing effects on the EGFR pathway in U251 glioma cells","volume":"29","author":"Liu","year":"2013","journal-title":"Oncol Rep"},{"key":"10.1016\/j.nano.2025.102861_bb1235","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1163\/156856209X415828","article-title":"Co-delivery of as-miR-21 and 5-FU by poly(amidoamine) dendrimer attenuates human glioma cell growth in vitro","volume":"21","author":"Ren","year":"2010","journal-title":"J Biomater Sci Polym Ed"},{"key":"10.1016\/j.nano.2025.102861_bb1240","first-page":"289","article-title":"Modulating microRNAs in cancer: next-generation therapies","volume":"19","author":"Arghiani","year":"2021","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.nano.2025.102861_bb1245","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2024.114492","article-title":"PAMAM\/miR-144 nanocarrier system inhibits the migration of gastric cancer by targeting mTOR signal transduction pathway","volume":"249","author":"Qian","year":"2025","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.nano.2025.102861_bb1250","article-title":"Enzyme-responsive branched glycopolymer-based nanoassembly for co-delivery of paclitaxel and Akt inhibitor toward synergistic therapy of gastric cancer","volume":"11","author":"Song","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.nano.2025.102861_bb1255","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1080\/17425247.2020.1730809","article-title":"Resistance of hepatocellular carcinoma to sorafenib can be overcome with co-delivery of PI3K\/mTOR inhibitor BEZ235 and sorafenib in nanoparticles","volume":"17","author":"Wu","year":"2020","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.nano.2025.102861_bb1260","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s40495-017-0113-2","article-title":"Plant flavone apigenin: an emerging anticancer agent","volume":"3","author":"Shankar","year":"2017","journal-title":"Curr Pharmacol Rep"},{"key":"10.1016\/j.nano.2025.102861_bb1265","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118814","article-title":"Rationalizing the therapeutic potential of apigenin against cancer","volume":"267","author":"Ahmed","year":"2021","journal-title":"Life Sci"},{"key":"10.1016\/j.nano.2025.102861_bb1270","doi-asserted-by":"crossref","DOI":"10.3390\/polym14173577","article-title":"Apigenin loaded lipoid-PLGA-TPGS nanoparticles for colon cancer therapy: characterization, sustained release, cytotoxicity, and apoptosis pathways","volume":"14","author":"Alfaleh","year":"2022","journal-title":"Polymers (Basel)"},{"key":"10.1016\/j.nano.2025.102861_bb1275","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105364","article-title":"Prospective therapeutic potential of Tanshinone IIA: an updated overview","volume":"164","author":"Ansari","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.nano.2025.102861_bb1280","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17010066","article-title":"Preparation of pH-responsive Tanshinone IIA-loaded calcium alginate nanoparticles and their anticancer mechanisms","volume":"17","author":"Ren","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.nano.2025.102861_bb1285","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jconrel.2022.12.028","article-title":"Applications and challenges of ultra-small particle size nanoparticles in tumor therapy","volume":"353","author":"Xu","year":"2023","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2025.102861_bb1290","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2019.100800","article-title":"Engineered nanomedicines with enhanced tumor penetration","volume":"29","author":"Ding","year":"2019","journal-title":"Nano Today"},{"key":"10.1016\/j.nano.2025.102861_bb1295","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.nantod.2014.04.008","article-title":"Challenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospects","volume":"9","author":"Barua","year":"2014","journal-title":"Nano Today"},{"key":"10.1016\/j.nano.2025.102861_bb1300","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/nrc1456","article-title":"High interstitial fluid pressure - an obstacle in cancer therapy","volume":"4","author":"Heldin","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.nano.2025.102861_bb1305","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nrc.2017.93","article-title":"Transport of drugs from blood vessels to tumour tissue","volume":"17","author":"Dewhirst","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.nano.2025.102861_bb1310","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jconrel.2016.03.022","article-title":"How successful is nuclear targeting by nanocarriers?","volume":"229","author":"Tammam","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2025.102861_bb1315","doi-asserted-by":"crossref","first-page":"15855","DOI":"10.1021\/acsami.5b03150","article-title":"Efficient delivery of DOX to nuclei of hepatic carcinoma cells in the subcutaneous tumor model using pH-sensitive pullulan-DOX conjugates","volume":"7","author":"Li","year":"2015","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.nano.2025.102861_bb1320","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/1567201811666140821110631","article-title":"Insights into cellular uptake of nanoparticles","volume":"12","author":"Kafshgari","year":"2015","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.nano.2025.102861_bb1325","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.nano.2016.02.019","article-title":"Ultrasmall inorganic nanoparticles: state-of-the-art and perspectives for biomedical applications","volume":"12","author":"Zarschler","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2025.102861_bb1330","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2019.102059","article-title":"Tumor penetration of Sub-10 nm nanoparticles: effect of dendrimer properties on their penetration in multicellular tumor spheroids","volume":"21","author":"Bugno","year":"2019","journal-title":"Nanomedicine-Nanotechnol Biol Med"},{"key":"10.1016\/j.nano.2025.102861_bb1335","doi-asserted-by":"crossref","DOI":"10.1128\/MMBR.00044-18","article-title":"Cross-domain and viral interactions in the microbiome","volume":"83","author":"Rowan-Nash","year":"2019","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.nano.2025.102861_bb1340","article-title":"Uptake of functional ultrasmall gold nanoparticles in 3D gut cell models","volume":"18","author":"Sokolova","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.nano.2025.102861_bb1345","article-title":"Engineered Ultrasmall Nanoparticle Drug-Immune Conjugates with \"Hit and Run\" Tumor Delivery to Eradicate Gastric Cancer","volume":"6","author":"Zhang","year":"2023","journal-title":"Adv Ther (Weinh)"},{"key":"10.1016\/j.nano.2025.102861_bb1350","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1021\/acsnano.8b00873","article-title":"Supraparticles: functionality from uniform structural motifs","volume":"12","author":"Wintzheimer","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2025.102861_bb1355","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.142971","article-title":"Aerosol additive manufacturing of multi-component supraparticles for Fenton reaction-assisted multi-modal anticancer treatment","volume":"465","author":"Park","year":"2023","journal-title":"Chem Eng J"},{"key":"10.1016\/j.nano.2025.102861_bb1360","doi-asserted-by":"crossref","first-page":"8969","DOI":"10.1039\/C8NR00641E","article-title":"Self-assembled nanodiamond supraparticles for anticancer chemotherapy","volume":"10","author":"Yu","year":"2018","journal-title":"Nanoscale"},{"key":"10.1016\/j.nano.2025.102861_bb1365","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2025.115087","article-title":"Ginsenoside Rb1 carbon nanodots: a green and promising nanomedicine for effective gastric cancer treatment","volume":"256","author":"Xiao","year":"2025","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.nano.2025.102861_bb1370","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1021\/acsnano.7b01032","article-title":"Ultrasmall magnetic CuFeSe(2) ternary nanocrystals for multimodal imaging guided Photothermal therapy of Cancer","volume":"11","author":"Jiang","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2025.102861_bb1375","doi-asserted-by":"crossref","first-page":"6987","DOI":"10.1158\/0008-5472.CAN-12-4477","article-title":"Supramolecular nanoparticles that target phosphoinositide-3-kinase overcome insulin resistance and exert pronounced antitumor efficacy","volume":"73","author":"Kulkarni","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.nano.2025.102861_bb1380","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.116870","article-title":"Cancer treatment and toxicity outlook of nanoparticles","volume":"237","author":"Neetika","year":"2023","journal-title":"Environ Res"},{"key":"10.1016\/j.nano.2025.102861_bb1385","doi-asserted-by":"crossref","first-page":"8487","DOI":"10.2147\/IJN.S170723","article-title":"Potential adverse effects of nanoparticles on the reproductive system","volume":"13","author":"Wang","year":"2018","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.nano.2025.102861_bb1390","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.nantod.2019.03.010","article-title":"Nanoparticle translocation and multi-organ toxicity: a particularly small problem","volume":"26","author":"Raftis","year":"2019","journal-title":"Nano Today"},{"key":"10.1016\/j.nano.2025.102861_bb1395","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17060929","article-title":"Toxicological considerations, toxicity assessment, and risk Management of Inhaled Nanoparticles","volume":"17","author":"Bakand","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2025.102861_bb1400","doi-asserted-by":"crossref","DOI":"10.1186\/s12989-014-0033-9","article-title":"Size dependent translocation and fetal accumulation of gold nanoparticles from maternal blood in the rat","volume":"11","author":"Semmler-Behnke","year":"2014","journal-title":"Part Fibre Toxicol"},{"key":"10.1016\/j.nano.2025.102861_bb1405","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.2174\/0929867321666140601162314","article-title":"Toxicity of nanoparticles","volume":"21","author":"Zoroddu","year":"2014","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.nano.2025.102861_bb1410","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/wnan.103","article-title":"Metal-based nanoparticles and their toxicity assessment","volume":"2","author":"Schrand","year":"2010","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"10.1016\/j.nano.2025.102861_bb1415","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00204-016-1797-5","article-title":"Protein bio-corona: critical issue in immune nanotoxicology","volume":"91","author":"Neagu","year":"2017","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.nano.2025.102861_bb1420","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1477-3155-11-26","article-title":"Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle","volume":"11","author":"Saptarshi","year":"2013","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.nano.2025.102861_bb1425","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1021\/acsnano.5b06439","article-title":"Adsorption and unfolding of a single protein triggers nanoparticle aggregation","volume":"10","author":"Dominguez-Medina","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.nano.2025.102861_bb1430","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1021\/es403864v","article-title":"Nanoparticles meet cell membranes: probing nonspecific interactions using model membranes","volume":"48","author":"Chen","year":"2014","journal-title":"Environ Sci Technol"},{"key":"10.1016\/j.nano.2025.102861_bb1435","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18010120","article-title":"The role of reactive oxygen species (ROS) in the biological activities of metallic nanoparticles","volume":"18","author":"Abdal Dayem","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nano.2025.102861_bb1440","doi-asserted-by":"crossref","first-page":"6441","DOI":"10.1021\/acsanm.1c00779","article-title":"Recent advances in nanoparticle-based cancer treatment: a review","volume":"4","author":"Bajpai","year":"2021","journal-title":"ACS Applied Nano Materials"},{"key":"10.1016\/j.nano.2025.102861_bb1445","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbsr.2025.100740","article-title":"Nanotechnology and nanosensors in personalized healthcare: a comprehensive review","volume":"47","author":"Ghorbian","year":"2025","journal-title":"Sensing and bio-sensing Research"},{"key":"10.1016\/j.nano.2025.102861_bb1450","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12050673","article-title":"The promise of nanotechnology in personalized medicine","volume":"12","author":"Alghamdi","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.nano.2025.102861_bb1455","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.addr.2012.06.006","article-title":"Nanotheranostics for personalized medicine","volume":"64","author":"Mura","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2025.102861_bb1460","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201706759","article-title":"Cell membrane coating nanotechnology","volume":"30","author":"Fang","year":"2018","journal-title":"Advanced materials"},{"key":"10.1016\/j.nano.2025.102861_bb1465","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/s13346-022-01252-0","article-title":"Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system","volume":"13","author":"Liu","year":"2023","journal-title":"Drug Deliv Transl Res"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963425000620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963425000620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T06:22:07Z","timestamp":1760336527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963425000620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":293,"alternative-id":["S1549963425000620"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2025.102861","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the PI3K\/Akt\/mTOR pathway with nanotechnology: A novel therapeutic strategy for gastrointestinal cancers","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2025.102861","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102861"}}